Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future
about
Switching off malignant mesothelioma: exploiting the hypoxic microenvironmentEfficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinomaZoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaThe role of interleukin-6 in malignant mesotheliomaCharacterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMTExemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this diseaseSurgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies.Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapyBAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state
P2860
Q29248727-EEFC15F6-CE26-48F1-AD92-4A55FD0081A2Q34785940-2C87C98A-EB16-4252-9C8E-FF5FE90117E1Q35176037-356506B2-2358-4A92-B5F5-202D6096ACB9Q35200628-083E7919-891D-4614-9F50-9541CE1FB906Q35275675-330FDA0D-8853-4F2E-AC63-39C8C8C06677Q35834928-9B46AF18-69D0-438A-B260-23619CB5EBDFQ35928957-4B0444CE-C66D-4438-B33B-CCE86C46540FQ37686318-856C852F-AA3B-46D4-9BBD-3E2C1D3DF23DQ38195607-038FDE6D-5EBA-4449-ABC0-9A4C9716EBC5Q39005410-6A75E1CC-016A-461D-A6DE-2B2935D95E93Q41869395-BD0CCD52-80CC-4DCA-B31D-D137F02EADEEQ52581757-0E4B6095-A8D6-42D3-A40E-78C7BA316C7DQ55022610-8876AB3F-1F5B-421B-A291-A20A0957F010Q57822522-0A4C7B3F-66A7-4188-923B-9E0553BD5D66Q57983113-259A151B-DBBE-4243-B6CE-E107D155F2C2
P2860
Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Chemotherapy for malignant ple ...... ement and a look to the future
@en
Chemotherapy for malignant ple ...... ment and a look to the future.
@nl
type
label
Chemotherapy for malignant ple ...... ement and a look to the future
@en
Chemotherapy for malignant ple ...... ment and a look to the future.
@nl
prefLabel
Chemotherapy for malignant ple ...... ement and a look to the future
@en
Chemotherapy for malignant ple ...... ment and a look to the future.
@nl
P2860
P1476
Chemotherapy for malignant ple ...... ement and a look to the future
@en
P2093
Anna K Nowak
P2860
P304
P356
10.3978/J.ISSN.2225-319X.2012.10.05
P577
2012-11-01T00:00:00Z